Home Services Structural Biology Services

Structural Biology Services

From AI-predicted hypotheses to experimentally validated molecular structures.

Creative Biostructure integrates sequence analysis, construct design, protein production, X-ray crystallography, cryo-EM, NMR, EPR spectroscopy, biophysical assays and computational refinement in one iterative workflow.

Explore Services
Gene to structureFlexible entry points
Multi-methodEvidence cross-validation
Decision-readyData + interpretation

Predict. Test. Refine. Repeat.

AI + Wet Lab
01

Computational hypothesis

Structure prediction, construct mapping, docking and dynamics prioritize testable questions.

02

Experimental design

Sample state, method, controls and acquisition strategy are selected around the question.

03

Physical evidence

X-ray, cryo-EM, NMR, MicroED and EPR reveal structure, distance restraints and dynamics.

04

Model refinement

Experimental constraints update the model and direct the next construct or experiment.

Output: a traceable evidence chain—not a prediction in isolation.

What Is Structural Biology?

Structural biology is the study of the three-dimensional structures, interactions and conformational states of biological molecules—especially proteins, nucleic acids and their complexes—using experimental measurements supported by computational analysis.

It connects molecular form with biological function. Structural evidence can reveal binding pockets, interfaces, catalytic arrangements, oligomeric states, flexibility and conformational change that are not fully resolved from sequence alone.

No single method answers every structural question. X-ray crystallography can provide atomic detail for crystallizable samples; cryo-EM is powerful for large or heterogeneous assemblies; NMR probes solution-state structure and dynamics; microscopy and biophysical assays add spatial, kinetic and thermodynamic evidence. Integrative structural biology combines these data types around one biological question.

Structure

Where are the atoms, domains or subunits?

Interaction

How do partners, ligands or antibodies bind?

Dynamics

Which states change with function or environment?

How Does Our Dry–Wet Closed Loop Work?

Computational models narrow the experimental search space. Wet-lab measurements test those hypotheses. The resulting evidence then guides the next design decision.

01

Define the decision

Translate the biological objective into a resolvable question: architecture, binding mode, interface, dynamics, state or mechanism.

02

Assess sequence and constructs

Use domain boundaries, disorder, transmembrane regions, conservation and predicted structure to design testable constructs.

03

Produce and qualify samples

Express, purify and assess identity, purity, monodispersity, stability, activity and complex formation before acquisition.

04

Prioritize experiments

Predicted models, docking and simulations help rank constructs, ligands, conformations and conditions—not replace physical testing.

05

Acquire orthogonal evidence

Combine coordinate or density methods with binding, stability and EPR distance-distribution data where dynamics or heterogeneity matter.

06

Refine, validate and iterate

Fit experimental constraints, review validation metrics, reconcile disagreements and feed insights into the next design cycle.

Why the loop matters

AI predictions are probabilistic. Experimental structures are also method- and sample-dependent. Iteration makes assumptions visible and improves confidence through cross-validation.

Explore AI-enhanced analysis →

Structural Biology Techniques Matched to the Question

Choose a standalone method or combine complementary technologies to resolve structure, interaction and dynamics across scales.

Which Structural Method Fits Your Target?

The best method depends on the decision, not only molecular weight. Sample behavior, flexibility, environment, resolution needs and available material all influence strategy.

Comparison of structural biology methods by sample fit, information and constraints
Method Strong fit Information gained Important constraint Typical output
X-ray crystallography Well-ordered soluble proteins and complexes High-resolution atomic coordinates and ligand interactions Requires crystals; conformational ensembles may be underrepresented Diffraction data, refined coordinates, validation statistics
Cryo-EM / SPA Large assemblies, membrane proteins, multiple states 3D density, architecture and conformational classes Grid behavior, preferred orientation and heterogeneity affect resolution Micrographs, 2D classes, density maps, atomic model where supported
NMR spectroscopy Smaller proteins, flexible regions, binding and dynamics Solution-state structure, chemical environment and motion Size, labeling, concentration and spectral overlap can limit analysis Spectra, assignments, restraints, structures and dynamics metrics
MicroED Microcrystalline peptides, proteins and small molecules Diffraction-based 3D structure from very small crystals Crystal thickness, radiation damage and data completeness matter Diffraction data and refined structural model
EPR spectroscopy Flexible proteins, membrane proteins, complexes and disordered systems with suitable spin-label sites Nanometer-scale distance distributions, conformational populations and changes in dynamics Requires strategic labeling and does not by itself produce a complete atomic structure Raw traces, distance-distribution profiles, restraints and model comparison
Integrative approach Flexible, heterogeneous or multi-component systems Cross-scale model constrained by complementary evidence Requires explicit uncertainty and compatibility assessment across datasets Evidence-weighted ensemble or architecture with provenance

Biophysical assays strengthen structural interpretation

Binding, stability, size and conformational assays—including EPR distance distributions—help test whether a structural model represents the relevant molecular state or ensemble.

SPR, BLI, ITC, MST and fluorescence-based assays can confirm affinity, kinetics, stoichiometry and thermodynamic behavior.

DSC, thermal shift, DLS, MALS, SEC and AUC can assess folding, aggregation, molecular weight and oligomeric state.

HDX-MS, EPR, CD, FTIR and complementary spectroscopy can map flexibility, secondary structure and environment-dependent changes.

Site-directed spin labeling and pulsed dipolar EPR can provide probability distributions of inter-spin distances. These restraints can test predicted conformations, refine low-resolution maps and compare ligand- or environment-dependent states.

What Biomolecules Can We Study?

Projects may begin with a sequence, construct, purified sample, complex or existing dataset.

Proteins

Soluble and membrane proteins, receptors, enzymes, antibodies, fragments, oligomers and disordered regions.

Nucleic acids

DNA, RNA, hybrids, regulatory elements and nucleic acid–protein complexes.

Biomolecular complexes

Protein–protein, protein–ligand, protein–peptide, antibody–antigen and macromolecular assemblies.

Dynamic states

Active/inactive states, folding intermediates, transient interactions, allosteric transitions and assembly pathways.

Representative protein structures illustrating membrane proteins, repeat proteins, beta barrels, superhelices and solenoid folds
Various structures of proteins.

Experimental Infrastructure for Structure Determination

Automated preparation, high-resolution acquisition and expert data analysis support projects from screening through validated models.

ARI Crystal Phoenix liquid handling system for automated protein crystallization screening

Automated crystallization

High-throughput screening and nanoliter dispensing.

300 kV cryo-electron microscope for high-resolution biomolecular structure determination

300 kV cryo-EM

High-resolution imaging of complexes and membrane proteins.

800 MHz NMR spectrometer for protein structure interaction and dynamics analysis

High-field NMR

Solution and solid-state structural measurements.

Protein crystal X-ray diffraction pattern used for structural data processing

Data acquisition & refinement

Processing pipelines with transparent validation metrics.

What Can You Submit?

  • ✓Gene or sequence: for construct and expression strategy development
  • ✓Expression construct or cells: for production and downstream structural work
  • ✓Purified protein, nucleic acid or complex: for feasibility and method-specific analysis
  • ✓Raw or processed data: for model building, refinement or independent interpretation

Exact purity, concentration, quantity, buffer and activity requirements vary by target and method.

What Can the Data Package Include?

  • Sample QC and feasibility findings
  • Raw and processed experimental data
  • Density maps, spectra or diffraction data
  • Refined structures and coordinates
  • Model and data validation metrics
  • Interaction and conformational analysis
  • Methods, parameters and figure files
  • Technical report and expert interpretation

Featured Case Studies of Structural Analysis

Review experimental images, structural outputs and downloadable summaries from representative X-ray crystallography and Cryo-TEM projects.

X-ray Crystallography for Fab–Antigen Complex Structural Analysis

This project focuses on elucidating the three-dimensional structure of a Fab–antigen complex using X-ray crystallography. The workflow begins with Fab preparation, complex formation and initial crystal screening, followed by diffraction analysis, density-map interpretation and model refinement.

Protein crystal X-ray diffraction pattern for Fab-antigen complex structural analysis
Figure 1. Protein crystal diffraction pattern.
Electron-density map of a Fab-antigen protein complex derived from X-ray crystallography data
Figure 2. Density map of protein complex.
Refined three-dimensional protein structure of a Fab-antigen complex
Figure 3. Protein structure of Fab–antigen complex.
Cover of the X-ray crystallography Fab-antigen complex case study
Case Study PDF

X-ray Crystallography for Fab–Antigen Complex Structural Analysis

Complete the short form to access the full background, methods, results and structural interpretation.

Cryo-TEM for CDXX Receptor Structural Analysis

This project analyzes the three-dimensional structure of a CDXX receptor and AB-X antibody complex using Cryo-TEM. Sample preparation is followed by data acquisition, image processing, single-particle classification, model building and refinement.

Representative 300 kV Cryo-TEM image of a CDXX receptor and antibody complex
Figure 1. Representative CDXX–antibody complex image.
Two-dimensional classification results for the CDXX receptor and antibody complex
Figure 2. Representative 2D classification results.
Cryo-TEM structural model showing antibody CDR interaction with the CDXX receptor
Figure 3. Interaction between antibody CDR and CDXX.
Cover of the Cryo-TEM CDXX receptor structural analysis case study
Case Study PDF

Cryo-TEM for CDXX Receptor Structural Analysis

Complete the short form to access the workflow, representative images and structural insights.

What Decisions Can Structural Biology Support?

Structural evidence supports target assessment, molecular engineering and mechanistic interpretation across discovery and development programs.

Drug Discovery

  • Target and pocket characterization
  • Protein–ligand binding modes
  • Structure-based design hypotheses
  • Lead optimization support

Protein Engineering

  • Mutation effect interpretation
  • Stability and interface design
  • Antibody–antigen mapping
  • Construct optimization

Mechanism Research

  • Structure–function relationships
  • Conformational state mapping
  • Allostery and molecular recognition
  • Assembly and transient interactions
Cover of the Creative Biostructure structure-based drug discovery brochure
Application Brochure

Structure-Based Drug Discovery

Explore how structural determination, computational modeling and interaction analysis can support target assessment and drug-design decisions.

Download
Cover of the Creative Biostructure Structural Biology Services brochure featuring membrane protein structure analysis
Service Brochure

Structural Biology Services

Review our integrated capabilities for protein and macromolecular structure analysis, illustrated through a membrane-protein project example.

Download Brochure

Research Publications Highlighting Our Structural Biology Expertise

The studies below identify specific structural biology contributions from Creative Biostructure. Article titles, journals, years and contribution summaries are presented together for direct review.

Peer-reviewed publications referencing Creative Biostructure structural biology support
Article Journal Year Contribution
APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation Alzheimer's & Dementia 2024 Creative Biostructure determined the three-dimensional crystal structure of purified 7C11.IgG Fab as a fee-for-service contribution.
A novel mechanism of herbicide action through disruption of pyrimidine biosynthesis Proceedings of the National Academy of Sciences 2023 Creative Biostructure provided X-ray crystallographic support for the structural investigation reported in the study.
Linoleic acid binds to SARS-CoV-2 RdRp and represses replication of seasonal human coronavirus OC43 Scientific Reports 2022 The work used a Creative Biostructure-produced complex structure of SARS-CoV-2 RNA polymerase with double-stranded RNA fragments.
Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffold European Journal of Medicinal Chemistry 2021 The authors report collaboration with Creative Biostructure to optimize survivin crystallization conditions for inhibitor-complex structure determination.
All major cholesterol-dependent cytolysins use glycans as cellular receptors Science Advances 2020 The authors acknowledge Creative Biostructure for protein chemical-shift assignment supporting the study.
Browse more publications →

Structural Biology FAQs

Clear answers to common questions about prediction, method choice, samples and deliverables.

View all FAQs →

No. AI models are valuable hypotheses, but experiments are needed to verify the physical sample state, ligand pose, local geometry, dynamics, oligomeric state and method-specific uncertainty.

Method selection depends on molecular size, sample homogeneity, flexibility, available quantity, crystallization behavior, environment and the structural or dynamic information required. Some questions benefit from an integrative strategy.

A project may combine detergent or lipid screening, stability and monodispersity assessment, nanodisc or liposome reconstitution, and cryo-EM, X-ray or NMR analysis selected for the target state.

EPR uses site-specific paramagnetic labels to provide nanoscale distance distributions and conformational-population information. These restraints can test predicted models, complement low-resolution density and reveal flexible or multiple states that a single static structure may not capture.

Projects can begin from a gene sequence, construct, expression system, purified protein, nucleic acid, complex or an existing structural dataset. Exact specifications are assessed for the target and method.

Depending on scope, deliverables may include quality-control results, raw and processed data, density maps or spectra, refined coordinates, validation metrics, interaction analysis, figures and a technical report.

Yes. Existing predictions can be treated as testable starting models and evaluated against structural, binding, stability or dynamics data. The validation plan should define which claims the experiments can and cannot support.

OUR VALUED PARTNERSHIPS
mit harvard stanford nih abbvie novartis amgen gsk regeneron sanofi
Online Inquiry

For Research or Industrial Raw Materials, Not for Personal Use!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Download Resource

Please fill in your information to download this resource.